Aztreonam

Seminars in Pediatric Infectious Diseases

Volumn 10, Issue 1, 1999, Pages 45-50

  Orlicek, S L ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIAL MENINGITIS; BONE INFECTION; DRUG USE; HUMAN; NEPHROTOXICITY; RESPIRATORY TRACT INFECTION; SEPSIS; UREMIA; URINARY TRACT INFECTION;

EID: 0032970574     PISSN: 10451870     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1045-1870(99)80009-0     Document Type: Article

References (52)

1. Imada A Kitano K Kintako K Sulfazecin and isosulfazecin, novel β-lactam antibiotics of bacterial origin Natur 289 1981 590 591
2. Sykes RB Cimarustiu CM Bonner DP Monocyclic β-lactam antibiotics produced by bacteria Nature 291 1981 489 491
3. Sykes RB Bonner DP Aztreonam: The first monobactam Am J Med 78 suppl A 1985 2 10
4. Neu HC Structure activity relations of new beta-lactam compounds and in vitro activity against common bacteria Rev Infect Dis 5 suppl 2 1983 319 336
5. Georgopapadakou NH Smith SA Sykes RB Mode of action of aztreonam Antimicrob Agents Chemother 21 1982 950
6. Barry AI Thornsberry C Jones RN Aztreonam: Antibacterial activity β-lactamase stability, and interpretive standards and quality control guide-lines for disk-diffusion susceptibility tests Rev Infect Dis 7 suppl 4 1985 S594 S604
7. Neu HC Azireonam activity, pharmacology, and clinical uses Am J Med 88 1990 2S 6S
8. Sykes RB Bonner DP Bush K Aztreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteria Antimicrob Agents Chemother 21 1982 85 92
9. Parry MF Aztreonam susceptibility testing: A retrospective analysis Am J Med 88 suppl 3C 1990 7S 11S
10. Fekete T Haitham T Woodwell J Comparative susceptibilities of Klebsiella species, Enterobacter species, and Pseudomonas aeruginosa to 11 antimicrobial agents in a tertiary care university hospital Am J Med 100 suppl 6A 1996 20S 25S
11. Fainstein V Weaver S Bodey GP Comparative in vitro study of SQ26,776 Antimicrob Agents Chemother 21 1982 294 298
12. Powell M Williams JD In vitro activities of aztreonam, imipenem, and amoxicillin-clavulanate against ampicillin-resistant Haemophilus influenzae Antimicrob Agents Chemother 31 1987 1871 1873
13. Giamarellou H Zissis NP Tagari G In vitro synergistic activities of aminoglycosides and new β-lactams against multiresistant Pseudomonas aeruginosa Antimicrob Agents Chemother 25 1984 531 536
14. Swabb EA Sugerman AA Stern M Oral bioavailability of the monobactam aztreonam (SQ 26.776) in healthy subjects Antimicrob Agents Chemother 23 1983 548 550
15. Welling GW Groen G Welling-Wester S Enzymatic inactivation of aztreonam by faecal enzyme preparations from healthy volunteers Infection 15 1987 188 191
16. Swabb EA Sugerman AA Platt TB Single-dose pharmacokinetics of the monobactam aztreonam (SQ 26,776) in healthy subjects Antimicrob Agents Chemother 21 1982 944 949
17. Swabb EA Sugerman AA Mckinstry DN Multiple-dose pharmacokinetics of the monobactam azthreonam (SQ 26,776) in healthy subjects Antimicrob Agents Chemother 23 1983 125 132
18. Swabb EA Review of the clinical pharmacology of the monobactam antibiotic aztreonam Am J Med 78 1985 11 18
19. Duma RJ Berry AJ Smith SM Penetration of aztreonam into cerebrospinal fluid of patients with and without inflamed meninges Antimicrob Agents Chemother 26 1984 730 733
20. Mihindu JC Scheld WM Bolton ND Pharmacokinetics of aztreonam in patients with various degrees of renal dysfunction Antimicrob Agents Chemother 24 1983 252 261
21. Gerig JS Bolton ND Swabb EA Effects of hemodialysis and peritoneal dialysis on aztreonam pharmacokinetics Kidney Int 26 1984 308 318
22. Stutman HR Marks MI Swabb EA Single-dose pharmacokinetics of aztreonam in peditric patients Antimicrob Agents Chemother 26 1984 196 199
23. (abstr) Stutman HR Marks MI Pharmacokinetics of two dosages of aztreonam in children Clin Res 34 1986 251A
24. Likitnukul S McCracken GHJ Threlkeld N Pharmacokinetics and plasma bactericidal activity of aztreonam in low-birth-weight infants Antimicrob Agents Chemother 31 1987 81 83
25. Cuzzolin I Fanos V Zambreri D Pharmacokinetics and renal tolerance of aztreonam in premature infants Antimicrob Agents Chemother 35 1991 1726 1728
26. Bendush CB Henry SA Newman TJ Aztreonam: Worldwide clinical experimence with the first monobactam J Med Special Issue 1986 30 36
27. Chartrand SA Safety and toxicity profile of aztreonam Pediatr Infect Dis J 8 1989 S120 S123
28. Tartaglione TA Duma RJ Qureshi GD In vitro and in vivo studies of the effect of aztreonam on platelet function and coagulation in normal volunteers Antimicrob Agents Chemother 30 1986 73 77
29. Newman TJ Dreslinski GR Tadros SS Safety profile of aztreonam in clinical trials Rev Infec Dis 7 suppl 4 1985 S648 S655
30. Adkinson NF Swabb EA Sugerman AA Immunology of the monobactam aztreonam Antimicrob Agents Chemother 25 1984 93 97
31. Saxon A Swabb EA Adkinson NF Investigation into the immunologic cross-reactivity of aztreonam with other beta-lactams Am J Med 78 suppl 2A 1985 19 26
32. Jensen T Koch G Piedersen SS Aztreonam for cystic fibrosis patients with hypersensitivity to other beta-lactams Lancet 1987 1319 1320
33. Giuliano M Jacobus NV Gorbach SL Effect of broad-spectrum parenteral antibiotics on composition of intestinal microflora of humans Antimicrob Agents Chemother 31 1987 202 206
34. Chandrasekar PH Smith BR LeFrock JL Enterococcal superinfection and colonization with aztreonam therapy Antimicrob Agents Chemother 26 1984 280 282
35. Louie TJ Chubb H Bow EJ Preservation of colonization resistance parameters during empiric therapy with aztreonam in the febrile neutropenic patient Rev Infect Dis 7 suppl 4 1985 S747 S761
36. Kiem GR Sibley PL Hines FA Parenteral toxicological profile of the monocyclic beta-lactam antibiotic SO 26,776 in mice, rats and dogs J Antimicrob Chemother 8 suppl E 1981 141
37. Stutman HR Parker KM Marks MI Potential of moxalactam and other new antimicrobial agents for bilirubin-albumin displacement in neonates Pediatrics 75 1985 294 298
38. Swabb EA Jenkins SA Muir JG Summary of worldwide clinical trials of aztreonam in patients with urinary tract infections Rev Infect Dis 7 suppl 4 1985 S772 S777
39. Kline MW Kaplan SL Mason EO Aztreonam therapy of gram-negative infections predominantly of the urinary tract in children Curr Ther Res 39 1986 625 631
40. Stutman HR Chartrand SA Tolentino T Aztreonam therapy for serious gram-negative infections in children Am J Dis Child 140 1986 1147 1151
41. Rusconi F Assael BM Boccazzi A Aztreonam in the treatment of severe urinary tract infections in pediatric patients Antimicrob Agents Chemother 30 1986 310 314
42. Bosso JA Black PG Matsen JM Efficacy of aztreonam in pulmonary exacerbations of cystic fibrosis Pediatr Infect Dis J 6 1987 393 397
43. Bosso JA Black PG Controlled trial of aztreonam vs. tobramycin and azlocillin for acute pulmonary exacerbations of cystic fibrosis Pediatr Infect Dis J 7 1988 171 176
44. Umana MA Odio CM Castro E Evaluation of aztreonam and ampicillin vs. amikacin and ampicillin for treatment of neonatal bacterial infections Pediatr Infect Dis J 9 1990 175 180
45. Lentnek AL Williams RR Aztreonam in the treament of gram-negative bacterial meningitis Rev Infect Dis 13 suppl 7 1991 S586 S590
46. Ayroza-Galvao PA Milstein-Kuschnaroff TM Mimica IM Aztreonam in the treatment of bacterial meningitis Chemotherapy 35 suppl 1 1989 39 44
47. Feris J Moledina WJ Rodriguez WJ Aztreonam in the treatment of gram-negative meningitis and other gram-negative infections Chemotherapy 35 suppl 1 1989 38
48. Girgis NI Abu EI Ella AH Farid A Parenteral aztreonam in the treatment of Haemophilus influenzae type b meningitis in Egyptian children Scand J Infect Dis 20 1988 111 112
49. Simons WJ Lee TJ Aztreonam in the treatment of bone and joint infections caused by gram-negative bacilli Rev Infect Dis 7 suppl 4 1985 S783 S788
50. Henry SA Overall clinical experience with aztreonam in the treatment of obstetric-gynecologic infections Rev Infect Dis 7 suppl 4 1985 S703 S708
51. Mohanty KC Deighton R Strachman RG Single intramuscular injection of aztreonam in the treatment of uncomplicated gonorrhea in women Curr Med Res Opin 10 1987 634 637
52. de Groot HG Hustinx PA Lampe AS Comparison of imipenem/cilastin with the combination of aztreonam and clindamycin in the treatment of intra-abdominal infections J Antimicrob Chemother 32 1993 491 500